Fig. 4
Forest plot of primary outcomes in higher-dose IDI and lower-dose IDI groups. a RR of the effective rate. b RR of adverse reaction rate. c WMD of CSF leukocytes. d WMD of CSF protein concentration
Fig. 4 | BMC Neurology
Forest plot of primary outcomes in higher-dose IDI and lower-dose IDI groups. a RR of the effective rate. b RR of adverse reaction rate. c WMD of CSF leukocytes. d WMD of CSF protein concentration